Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Urology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Trial Demonstrates Talazoparib Extends Prostate Cancer Survival
August 2025
The TALAPRO-2 study enrolled 805 patients from 200 centres across 26 countries, including North America, Europe, Israel, South America, South Africa, and the Asia–Pacific region.
Read more
22 Aug 2025
Trial Demonstrates Talazoparib Extends Prostate Cancer Survival
The TALAPRO-2 study enrolled 805 patients from 200 centres across 26 countries, including North America, Europe, Israel, South America, South Africa, and the Asia–Pacific region.
20 Aug 2025
Pyridostigmine Boosts Recovery in Underactive Bladder Post-TURP
Taken together, the findings suggest that targeted augmentation of cholinergic signalling may help bridge the gap between anatomical de-obstruction and functional recovery in BOO-mediated UAB.
18 Aug 2025
Low Testosterone Linked to Worse Prostate Cancer Outcomes
While MRI performance does not appear to depend on testosterone and inter-reader agreement is high, open questions remain, including whether PSMA PET or genomic markers could further refine early detection.
16 Aug 2025
Overactive Bladder Predicts Hypotension Risk After Spinal Anaesthesia
The authors hypothesised that, in women with OAB, the additional sympathetic blockade produced by spinal anaessthesia would further unmask parasympathetic dominance.
14 Aug 2025
New PSA-Based Index Improves Prediction of High-Grade Prostate Cancer
Researchers have developed a PSA-based index incorporating MRI measurements of periprostatic fat that significantly improves the prediction of high-grade prostate cancer.
12 Aug 2025
Study Finds PLR Improves Prostate Cancer Detection Accuracy
Find out more about the role of platelet-to-lymphocyte ratio in improving prostate cancer detection.
10 Aug 2025
AI Autocontouring Tool Shows Promise in Prostate Cancer Radiotherapy Planning
AI-assisted autocontouring safely outlines organs for prostate radiotherapy, study finds—though manual edits are still needed for the prostate itself.
8 Aug 2025
Not All Low-Grade Prostate Cancer Is Low Risk
A major study shows that nearly 1 in 6 men with biopsy Grade Group 1 prostate cancer are at higher risk than previously assumed, with outcomes comparable to intermediate-grade disease.
Loading posts...
1
2
3
…
36
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View